Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Bupropion

Known as: Amfebutamone, (+-)-1-(3-Chlorophenyl)-2-((1,1-dimethylethyl)amino)-1-propanone, BUP 
An aminoketone with antidepressant activity. The molecular mechanism of the antidepressant effect of bupropion is unknown. This agent does not… Expand
National Institutes of Health

Related topics

Related topics

39 relations
12 HR Bupropion Hydrochloride 100 MG Extended Release Oral Tablet [Wellbutrin]12 HR Bupropion Hydrochloride 150 MG Extended Release Oral Tablet24 HR Bupropion Hydrochloride 300 MG Extended Release Oral Tablet [Wellbutrin]24 HR Bupropion hydrobromide 348 MG Extended Release Oral Tablet [Aplenzin]
Expand

Broader (5)

Antidepressive AgentsAntidepressive Agents, Second-GenerationBupropion HydrochlorideCytochrome P-450 CYP2D6 Inhibitors
Expand

Narrower (9)

AplenzinBudeprionContraveQuomen
Expand

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2019
Review
2019
Obesity and nonalcoholic fatty liver disease: From pathophysiology to therapeutics.
The obesity epidemic is closely associated with the rising prevalence and severity of nonalcoholic fatty liver disease (NAFLD… Expand
  • figure 1
  • figure 2
  • table 1
  • table 2
Review
2019
Review
2019
Pharmacological interventions targeting anhedonia in patients with major depressive disorder: A systematic review
&NA; Anhedonia is defined as a diminished ability to experience interest or pleasure, and is a critical psychopathological… Expand
  • figure 1
Review
2018
Review
2018
Addressing the Side Effects of Contemporary Antidepressant Drugs: A Comprehensive Review
Randomized trials have shown that selective serotonin reuptake inhibitors (SSRIs) and serotonin-norepinephrine reuptake… Expand
  • table 1
  • table 2
  • table 3
  • table 4
  • table 5
Review
2018
Review
2018
Comparative efficacy and tolerability of medications for attention-deficit hyperactivity disorder in children, adolescents, and adults: a systematic review and network meta-analysis
Summary Background The benefits and safety of medications for attention-deficit hyperactivity disorder (ADHD) remain… Expand
  • figure 1
  • figure 2
  • figure 3
  • table 2
  • figure 4
Review
2017
Review
2017
2016 AHA/ACC Guideline on the Management of Patients With Lower Extremity Peripheral Artery Disease: Executive Summary
Preamble Since 1980, the American College of Cardiology (ACC) and American Heart Association (AHA) have translated scientific… Expand
  • table 1
  • table 2
  • table 3
  • table 5
  • table 6
Highly Cited
2006
Highly Cited
2006
Bupropion-SR, sertraline, or venlafaxine-XR after failure of SSRIs for depression.
BACKGROUND After unsuccessful treatment for depression with a selective serotonin-reuptake inhibitor (SSRI), it is not known… Expand
  • table 1
  • table 1
  • table 2
  • table 3
  • figure 2
Highly Cited
2006
Highly Cited
2006
Efficacy of Varenicline, an 42 Nicotinic Acetylcholine Receptor Partial Agonist, vs Placebo or Sustained-Release Bupropion for Smoking Cessation A Randomized Controlled Trial
ContextVarenicline, a partial agonist at the α4β2 nicotinic acetylcholine receptor, has the potential to aid smoking cessation by… Expand
Highly Cited
2006
Highly Cited
2006
Varenicline, an α4β2 Nicotinic Acetylcholine Receptor Partial Agonist, vs Sustained-Release Bupropion and Placebo for Smoking Cessation: A Randomized Controlled Trial
ContextThe α4β2 nicotinic acetylcholine receptors (nAChRs) are linked to the reinforcing effects of nicotine and maintaining… Expand
  • figure 1
  • table 1
  • figure 2
  • figure 3
  • table 2
Highly Cited
1999
Highly Cited
1999
A controlled trial of sustained-release bupropion, a nicotine patch, or both for smoking cessation.
BACKGROUND AND METHODS Use of nicotine-replacement therapies and the antidepressant bupropion helps people stop smoking. We… Expand
  • figure 1
  • figure 2
  • table 3
Highly Cited
1997
Highly Cited
1997
A Comparison of Sustained-Release Bupropion and Placebo for Smoking Cessation
Background and Methods Trials of antidepressant medications for smoking cessation have had mixed results. We conducted a double… Expand
  • table 2
  • figure 1
  • figure 2
  • figure 3
  • table 3
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy, Terms of Service, and Dataset License
ACCEPT & CONTINUE